Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.99 USD | +15.41% | +10.90% | +11.13% |
May. 10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
May. 09 | Zura Bio Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.13% | 377M | |
+9.89% | 115B | |
+11.92% | 106B | |
-2.59% | 21.96B | |
-12.59% | 21.87B | |
-5.29% | 19.21B | |
-3.85% | 18.08B | |
-38.57% | 17.71B | |
+7.01% | 14.32B | |
+35.74% | 12.42B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Piper Sandler Starts Zura Bio With Overweight Rating, $26 Price Target